Could a Three-Drug cocktail outsmart recurrent breast cancer?
Disease control
Recruiting now
This study is for people with a type of breast cancer called triple-negative that has come back after initial treatment. The researchers want to see if adding a drug called bevacizumab to the standard combination of pembrolizumab and paclitaxel can help control the cancer longer.…
Phase: PHASE2 • Sponsor: Yukinori Ozaki • Aim: Disease control
Last updated May 19, 2026 11:48 UTC